X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (41) 41
male (31) 31
middle aged (31) 31
hematology (30) 30
aged (25) 25
female (25) 25
adult (21) 21
index medicus (21) 21
oncology (18) 18
expression (14) 14
aged, 80 and over (12) 12
leukemia (11) 11
prognosis (11) 11
cancer (10) 10
chemotherapy (10) 10
disease-free survival (10) 10
adolescent (9) 9
leukemia-lymphoma, adult t-cell - drug therapy (9) 9
treatment outcome (9) 9
lymphoma (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
acute myeloid-leukemia (6) 6
leukemia/lymphoma (6) 6
medicine, general & internal (6) 6
mogamulizumab (6) 6
t cells (6) 6
transplantation (6) 6
immunophenotyping (5) 5
kaplan-meier estimate (5) 5
leukemia-lymphoma, adult t-cell - mortality (5) 5
survival (5) 5
activation (4) 4
analysis (4) 4
antibodies, monoclonal, humanized - administration & dosage (4) 4
blotting, southern (4) 4
burkitt lymphoma - genetics (4) 4
ccr4 (4) 4
child (4) 4
chronic myeloid leukemia (4) 4
cyclophosphamide - therapeutic use (4) 4
disease (4) 4
gene expression regulation, leukemic (4) 4
inv (4) 4
leukemia-lymphoma, adult t-cell - immunology (4) 4
leukemia-lymphoma, adult t-cell - pathology (4) 4
lymphocytes t (4) 4
lymphomas (4) 4
medicine & public health (4) 4
mutation (4) 4
non-hodgkin's lymphomas (4) 4
non-hodgkins-lymphoma (4) 4
oncology, experimental (4) 4
research (4) 4
virus type-i (4) 4
abnormalities (3) 3
acute myeloid leukemia (3) 3
adult t-cell leukemia/lymphoma (3) 3
age factors (3) 3
alleles (3) 3
animals (3) 3
anthracyclines (3) 3
antibodies, monoclonal, humanized - therapeutic use (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
biomarkers, tumor - analysis (3) 3
c-kit (3) 3
case report (3) 3
cd34 (3) 3
cells (3) 3
chop (3) 3
clinical-significance (3) 3
combination (3) 3
corticosteroids (3) 3
cyclophosphamide (3) 3
cyclophosphamide - administration & dosage (3) 3
differentiation (3) 3
dna methylation (3) 3
dna, viral - analysis (3) 3
doxorubicin - therapeutic use (3) 3
elderly-patients (3) 3
genes (3) 3
imatinib (3) 3
leukemia, myeloid, acute - mortality (3) 3
methylation (3) 3
mice (3) 3
multivariate analysis (3) 3
neoplasm proteins - genetics (3) 3
pebp2β/myh11 (3) 3
polymerase chain reaction (3) 3
receptors, antigen, t-cell - genetics (3) 3
retrospective studies (3) 3
rna, messenger - genetics (3) 3
rna, neoplasm - genetics (3) 3
survival analysis (3) 3
therapy (3) 3
translocation (3) 3
translocation, genetic (3) 3
tumor cells, cultured (3) 3
vincristine - therapeutic use (3) 3
young adult (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Hematology, ISSN 0925-5710, 2/2018, Volume 107, Issue 2, pp. 185 - 193
Journal Article
Journal Article
Cancer Science, ISSN 1347-9032, 10/2017, Volume 108, Issue 10, pp. 2022 - 2029
Journal Article
Annals of Hematology, ISSN 0939-5555, 1/2019, Volume 98, Issue 1, pp. 83 - 91
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 24, pp. 2570 - 2577
Journal Article
INTERNAL MEDICINE, ISSN 0918-2918, 2019, Volume 58, Issue 19, pp. 2879 - 2885
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2015, Volume 169, Issue 5, pp. 672 - 682
Summary This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti‐CC chemokine receptor 4... 
mogamulizumab | randomized phase II study | CCR4 | adult T‐cell leukaemia‐lymphoma | antibody therapy | Adult T-cell leukaemia-lymphoma | Mogamulizumab | Antibody therapy | Randomized phase II study | adult T-cell leukaemia-lymphoma | MONOCLONAL-ANTIBODY KW-0761 | RECEPTOR | LEUKEMIA/LYMPHOMA | HEMATOLOGY | EXPRESSION | ASSOCIATION | TRANSPLANTATION | Doxorubicin - therapeutic use | Nitrosourea Compounds - adverse effects | Prednisolone - adverse effects | Nitrosourea Compounds - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Carboplatin - therapeutic use | Vindesine - adverse effects | Vindesine - therapeutic use | Aged, 80 and over | Adult | Female | Prednisolone - therapeutic use | Etoposide - adverse effects | Leukemia-Lymphoma, Adult T-Cell - mortality | Etoposide - therapeutic use | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Chemotherapy | Lymphomas | T cells | Leukemia | Cancer | Haematological Malignancy | Research Paper
Journal Article
Cancer Science, ISSN 1347-9032, 10/2009, Volume 100, Issue 10, pp. 1842 - 1847
We evaluated the usefulness of prognostic markers in patients with diffuse large B-cell lymphoma (DLBCL) treated with cyclophosphamide, vincristine,... 
SURVIVAL | GENE | ONCOLOGY | BCL-2 PROTEIN EXPRESSION | R-CHOP | NON-HODGKINS-LYMPHOMA | CLASSIFICATION | GERMINAL CENTER | TISSUE MICROARRAY | CHEMOTHERAPY PLUS RITUXIMAB | ELDERLY-PATIENTS | Immunohistochemistry | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Male | Neprilysin - biosynthesis | Interferon Regulatory Factors - biosynthesis | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Neprilysin - genetics | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Antibodies, Monoclonal, Murine-Derived | Lymphoma, Large B-Cell, Diffuse - drug therapy | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Interferon Regulatory Factors - genetics | Rituximab | DNA-Binding Proteins - genetics | Proto-Oncogene Proteins c-bcl-2 - biosynthesis | Lymphoma, Large B-Cell, Diffuse - mortality | Drug Resistance, Neoplasm - genetics | Antibodies, Monoclonal - administration & dosage | Aged | DNA-Binding Proteins - biosynthesis | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Proto-Oncogene Proteins c-bcl-6 | Evaluation | Medical colleges | Anthracyclines | Corticosteroids | Oncology, Experimental | Multiple myeloma | Research | Cyclophosphamide | Analysis | Biological markers | Prednisolone | Hydrogen bomb | Cancer | Index Medicus
Journal Article